• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).

作者信息

Thrumurthy Sri Ganeshamurthy, Lewis Christopher John, Pritchard Susan, Armstrong Gordon, Attwood Stephen Edwin Arthur

出版信息

Surg Endosc. 2012 Jan;26(1):291-2. doi: 10.1007/s00464-011-1842-7.

DOI:10.1007/s00464-011-1842-7
PMID:21853395
Abstract
摘要

相似文献

1
Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).致编辑的信的回复：关于：正常食管黏膜、巴雷特食管、发育异常及腺癌与消融后黏膜中COX-2、Ki-67和BCL-2表达的比较及其对消融治疗的意义（网络优先发表）
Surg Endosc. 2012 Jan;26(1):291-2. doi: 10.1007/s00464-011-1842-7.
2
Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.比较 COX-2、Ki-67 和 BCL-2 在正常食管黏膜、Barrett 食管、异型增生和腺癌及消融后黏膜中的表达，以及对消融治疗的影响。
Surg Endosc. 2011 Aug;25(8):2564-9. doi: 10.1007/s00464-011-1587-3. Epub 2011 Feb 27.
3
Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma.Ki-67和Bax在食管黏膜中的表达可能对Barrett食管、发育异常及腺癌的消融治疗具有重要意义。
Surg Endosc. 2012 Jan;26(1):283-4. doi: 10.1007/s00464-011-1864-1.
4
Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.细胞凋亡的抑制不会促进巴雷特食管的肿瘤生长。
Mod Pathol. 1999 Mar;12(3):239-50.
5
High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.巴雷特食管中的高级别异型增生和浅表腺癌：组织学定位及p53、p21和Bcl-2癌蛋白的表达
Virchows Arch. 2003 Jan;442(1):18-24. doi: 10.1007/s00428-002-0674-1. Epub 2002 Sep 24.
6
Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.凋亡相关蛋白在巴雷特化生-发育异常-癌序列中的表达：向更具抗性表型的转变。
Hum Pathol. 2002 Jul;33(7):686-92. doi: 10.1053/hupa.2002.124908.
7
Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus.巴雷特食管腺癌中细胞周期相关因子、癌基因表达及细胞增殖的免疫组织学研究
Oncol Rep. 2003 Mar-Apr;10(2):427-31.
8
c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.c-Myc过表达与食管化生-发育异常-腺癌序列密切相关。
Dis Esophagus. 2007;20(3):212-6. doi: 10.1111/j.1442-2050.2007.00673.x.
9
Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus.巴雷特食管发育异常-癌序列中Ki-67、p53和Bcl-2表达的分析。
Oncol Rep. 1999 Jul-Aug;6(4):877-82. doi: 10.3892/or.6.4.877.
10
COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.COX-2、CDX2和CDC2免疫组化评估巴雷特食管发育异常-癌进展情况。
Dig Liver Dis. 2007 Apr;39(4):305-11. doi: 10.1016/j.dld.2007.01.011. Epub 2007 Feb 16.

本文引用的文献

1
Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.比较 COX-2、Ki-67 和 BCL-2 在正常食管黏膜、Barrett 食管、异型增生和腺癌及消融后黏膜中的表达，以及对消融治疗的影响。
Surg Endosc. 2011 Aug;25(8):2564-9. doi: 10.1007/s00464-011-1587-3. Epub 2011 Feb 27.
2
Global epidemiology of Barrett's esophagus.巴雷特食管的全球流行病学。
Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):123-30. doi: 10.1586/egh.10.82.
3
Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
幽门螺杆菌感染对慢性胃食管反流大鼠模型巴雷特食管和食管腺癌形成的影响。
Helicobacter. 2011 Feb;16(1):66-77. doi: 10.1111/j.1523-5378.2010.00811.x.
4
A national study of Helicobactor pylori infection in gastric biopsy specimens.一项全国性的胃活检标本中幽门螺杆菌感染的研究。
Gastroenterology. 2010 Dec;139(6):1894-1901.e2; quiz e12. doi: 10.1053/j.gastro.2010.08.018. Epub 2010 Aug 19.
5
Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.食管胃结合部腺癌：发病率、特征和治疗策略。
Gastric Cancer. 2010 Jun;13(2):63-73. doi: 10.1007/s10120-010-0555-2. Epub 2010 Jul 3.
6
Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population.成人中文人群中腐蚀性食管炎和 Barrett 食管的患病率。
Endoscopy. 2009 Dec;41(12):1011-7. doi: 10.1055/s-0029-1215291. Epub 2009 Dec 4.
7
Risk factors for esophageal cancer development.食管癌发生的危险因素。
Surg Oncol Clin N Am. 2009 Jul;18(3):469-85. doi: 10.1016/j.soc.2009.03.005.
8
Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis.幽门螺杆菌感染与巴雷特食管：一项系统评价和荟萃分析。
Am J Gastroenterol. 2009 Feb;104(2):492-500; quiz 491, 501. doi: 10.1038/ajg.2008.37. Epub 2009 Jan 6.
9
Esophageal adenocarcinoma in "mice and men": back to basics!
Am J Gastroenterol. 2008 Sep;103(9):2367-72. doi: 10.1111/j.1572-0241.2008.02004.x.
10
Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.辛伐他汀对巴雷特腺癌细胞生长的抑制作用：COX-2及凋亡相关蛋白的参与
J Physiol Pharmacol. 2007 Aug;58 Suppl 3:141-8.